MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,391 | -12.6% | 4,474 | -8.3% | 0.00% | – |
| Q1 2023 | $3,878 | +71.2% | 4,880 | -14.9% | 0.00% | – |
| Q4 2022 | $2,265 | -100.0% | 5,735 | +10.5% | 0.00% | – |
| Q3 2022 | $7,319,000 | -78.1% | 5,191 | -81.4% | 0.00% | – |
| Q2 2022 | $33,401,000 | +147.0% | 27,834 | +496.9% | 0.00% | – |
| Q1 2022 | $13,523,000 | -54.0% | 4,663 | -29.7% | 0.00% | – |
| Q4 2021 | $29,380,000 | -26.2% | 6,632 | +21.3% | 0.00% | – |
| Q3 2021 | $39,800,000 | +299.0% | 5,467 | +436.0% | 0.00% | – |
| Q2 2021 | $9,976,000 | -73.8% | 1,020 | -68.3% | 0.00% | – |
| Q1 2021 | $38,113,000 | +27.1% | 3,219 | -15.8% | 0.00% | – |
| Q4 2020 | $29,980,000 | -9.3% | 3,824 | -21.3% | 0.00% | – |
| Q3 2020 | $33,062,000 | +571.0% | 4,862 | +641.2% | 0.00% | – |
| Q2 2020 | $4,927,000 | -86.8% | 656 | -89.0% | 0.00% | – |
| Q1 2020 | $37,460,000 | +9.1% | 5,965 | +163.4% | 0.00% | – |
| Q4 2019 | $34,337,000 | +30.2% | 2,265 | -11.9% | 0.00% | – |
| Q3 2019 | $26,368,000 | +10.2% | 2,570 | +58.4% | 0.00% | – |
| Q2 2019 | $23,924,000 | -51.8% | 1,622 | -46.2% | 0.00% | – |
| Q1 2019 | $49,641,000 | – | 3,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 8,008,204 | $50,292,000 | 45.98% |
| Casdin Capital, LLC | 2,971,034 | $18,658,000 | 1.98% |
| Alphabet Inc. | 3,339,138 | $20,970,000 | 1.38% |
| Opaleye Management Inc. | 434,712 | $2,730,000 | 0.72% |
| Bleichroeder LP | 251,875 | $1,582,000 | 0.41% |
| Eventide Asset Management | 1,789,646 | $11,239,000 | 0.36% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,089,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 4,059,789 | $25,495,000 | 0.31% |
| Leap Investments LP | 12,600 | $79,000 | 0.12% |
| Aries Wealth Management | 12,000 | $77,000 | 0.06% |